- Home
- RCMT vs XGN Comparison
RCMT vs XGN Comparison
Compare RCMT & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- XGN
- Stock Information
- Founded
- RCMT 1971
- XGN 2002
- Country
- RCMT United States
- XGN United States
- Employees
- RCMT N/A
- XGN N/A
- Industry
- RCMT Professional Services
- XGN Medical Specialities
- Sector
- RCMT Consumer Discretionary
- XGN Health Care
- Exchange
- RCMT Nasdaq
- XGN Nasdaq
- Market Cap
- RCMT 172.2M
- XGN 138.3M
- IPO Year
- RCMT N/A
- XGN 2019
- Fundamental
- Price
- RCMT $25.94
- XGN $10.10
- Analyst Decision
- RCMT Strong Buy
- XGN Strong Buy
- Analyst Count
- RCMT 2
- XGN 4
- Target Price
- RCMT $33.50
- XGN $11.75
- AVG Volume (30 Days)
- RCMT 50.7K
- XGN 374.8K
- Earning Date
- RCMT 08-06-2025
- XGN 07-29-2025
- Dividend Yield
- RCMT N/A
- XGN N/A
- EPS Growth
- RCMT N/A
- XGN N/A
- EPS
- RCMT 1.76
- XGN N/A
- Revenue
- RCMT $299,916,000.00
- XGN $58,862,000.00
- Revenue This Year
- RCMT $16.29
- XGN $19.68
- Revenue Next Year
- RCMT $6.16
- XGN $13.68
- P/E Ratio
- RCMT $14.51
- XGN N/A
- Revenue Growth
- RCMT 11.01
- XGN 3.89
- 52 Week Low
- RCMT $13.18
- XGN $2.38
- 52 Week High
- RCMT $27.24
- XGN $10.29
- Technical
- Relative Strength Index (RSI)
- RCMT 63.03
- XGN 77.40
- Support Level
- RCMT $23.82
- XGN $9.39
- Resistance Level
- RCMT $25.11
- XGN $9.90
- Average True Range (ATR)
- RCMT 1.28
- XGN 0.44
- MACD
- RCMT 0.14
- XGN 0.03
- Stochastic Oscillator
- RCMT 97.83
- XGN 88.52
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.